plus extended-release dipyridamole (200 mg) given twice daily, or clopidogrel (75 mg) given once daily. The study was sponsored by the maker of the aspirin/dipyridamole combination (Aggrenox).

Participants, all event-free after 6 to 18 months following PCI, were randomized 1:1 to receive either clopidogrel (75 mg daily) or aspirin (100 mg daily). Subgroups were classified based on HBR ...

as many as 30% of patients on maintenance clopidogrel (75 mg/day) may show elevated platelet reactivity. Earlier studies also seem to indicate that reloading patients already on maintenance ...